CliffBio
small molecule

PAROXETINE HYDROCHLORIDE

PAROXETINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand namePAROXETINE HYDROCHLORIDE
Active ingredientPAROXETINE HYDROCHLORIDE
StrengthEQ 37.5MG BASE
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2017
Marketing statusDISCN

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.